Kevin S. Boyle, Sr.
Equibles does not estimate personal net worth.
About Kevin S. Boyle, Sr.
Earlier roles on record: Board Member and CEO at Alaunos Therapeutics, Inc. (TCRT) until December 22, 2023. Alaunos Therapeutics, Inc. reported in an 8-K filed December 28, 2023 that Kevin S. Boyle, Sr. resigned as board of directors, effective December 22, 2023. Alaunos Therapeutics, Inc. reported in an 8-K filed December 28, 2023 that Kevin S. Boyle, Sr. was terminated as Chief Executive Officer, effective December 22, 2023. The proxy statement of Alaunos Therapeutics, Inc. reports total compensation of $392,500 for Kevin S. Boyle, Sr. in fiscal 2024, including a base salary of $317,500. Disclosed compensation is on record for 3 fiscal years.
“Pursuant to the terms of his employment agreement, upon his termination Mr. Boyle was deemed to automatically resign from the Company's board of directors.”
“On December 22, 2023, Alaunos Therapeutics, Inc. (the "Company") entered into a Separation and Release Agreement, effective December 22, 2023, with Kevin S. Boyle, Sr. (the "Separation Agreement"), the Company's Chief Executive Officer, in connection with Mr. Boyle's termination.”
Affiliation history
-
2021-08-30–2023-12-22
-
2021-08-30–2023-12-22
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Alaunos Therapeutics, Inc. (TCRT) | Former Chief Executive Officer | $317,500 | $392,500 |
| 2022 | Alaunos Therapeutics, Inc. (TCRT) | Chief Executive Officer | $600,000 | $1,792,818 |
| 2021 | Alaunos Therapeutics, Inc. (TCRT) | Chief Executive Officer | $200,000 | $4,573,753 |